by Stephen Levin
One of the most challenging aspects of treating cardiovascular disease is that, viewed as a whole, heart disease is like...
Heart failure is a huge growing market in which devices are looking to succeed where drugs have provided only limited benefit. Paracor is taking on the role of David In a field dominated by the Goliaths in cardiac rhythm management and their powered devices. The company is betting that its strategy to focus first on a mechanical approach offers a better alternative for many patients not well-served by current therapies.
by Stephen Levin
One of the most challenging aspects of treating cardiovascular disease is that, viewed as a whole, heart disease is like...